Historical record - last NADAC effective date: 5/22/2019
Product Information
DICLOFENAC-MISOPROST 50-200 TB is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $1.7947 per EA under NDC 65162043603. Its NADAC has been published 94 times since Aug 9, 2017.
FDA first approved this application on Nov 25, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50; 200 mg/1; ug/1
Manufacturer
Amneal Pharmaceuticals LLCNDC
65162043603
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
5/22/2019
Active Ingredients
DICLOFENAC SODIUM; MISOPROSTOLApproval Type
Generic (ANDA)
FDA Application
ANDA203995FDA Approved
11/25/2016
TE Code
AB
On Market Since
12/1/2016
Pharmacological Classes
Price Statistics
The NADAC for DICLOFENAC-MISOPROST 50-200 TB has been published 94 times since Aug 9, 2017, and over the history we have for it it has declined 17.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7947 per EA |
|---|---|
| All-time high | $2.1865 (Aug 16, 2017) |
| All-time low | $1.6388 (Jan 23, 2019) |
| Median price | $1.8359 |
| Average price | $1.8735 |
| Largest weekly change | +20.7% (Feb 20, 2019) |
| Weeks tracked | 94 |
| Tracking since | Aug 9, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-17.9%
Last surveyed May 22, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 62% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DICLOFENAC-MISOPROST 50-200 TB?
The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC-MISOPROST 50-200 TB, manufactured by Amneal Pharmaceuticals LLC, is $1.7947 per EA (NDC 65162043603), effective May 22, 2019.
How has the price of DICLOFENAC-MISOPROST 50-200 TB changed over time?
Over the history we have for it, the NADAC for DICLOFENAC-MISOPROST 50-200 TB has declined 17.9%. It has been tracked across 94 weekly CMS publications since Aug 9, 2017.
What are the highest and lowest recorded NADAC prices for DICLOFENAC-MISOPROST 50-200 TB?
Since Aug 9, 2017, the NADAC for DICLOFENAC-MISOPROST 50-200 TB has ranged from a low of $1.6388 (Jan 23, 2019) to a high of $2.1865 (Aug 16, 2017), with a median of $1.8359 per EA.
Are there cheaper alternatives to DICLOFENAC-MISOPROST 50-200 TB?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DICLOFENAC-MISOPROSTOL DR 50-0.2 MG TABLET, is $0.6867 per EA — about 62% below DICLOFENAC-MISOPROST 50-200 TB.
Who manufactures DICLOFENAC-MISOPROST 50-200 TB?
DICLOFENAC-MISOPROST 50-200 TB (NDC 65162043603) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.